Prompteneering. Open the library →

Risk-Based Monitoring Plan Designer for Multi-Center Phase II/III Trials for Policy Refresh Change-control Review

Designs a comprehensive Risk-Based Monitoring plan for a multi-center Phase II/III trial aligned to FDA and EMA RBM guidance, defining centralized statistical monitoring thresholds and on-site visit triggers.

Open this agent in the library →

More Clinical Monitoring & Risk-Based Management agents

All Clinical Monitoring & Risk-Based Management agents · All Clinical Trials & Regulatory Affairs agents